Aurobindo Pharma Limited — Important, 28-04-2025: General Updates

A fire incident occurred at Aurobindo Pharma's wholly owned subsidiary, Lyfius Pharma Private Limited, affecting their Penicillin-G manufacturing facility in Kakinada SEZ. The fire, which happened in the coal crusher area, caused damage to ancillary equipment but did not impact the core manufacturing infrastructure. Fortunately, no injuries were reported, and the group anticipates no material effect on operations or financials. Operations at the facility will be paused for approximately 20 to 25 days while a thorough assessment of the damage and necessary equipment replacements are underway. The facility is insured, providing reassurance regarding financial implications. Stakeholders are encouraged to stay informed as Aurobindo Pharma prioritizes safety and quality during this period.